Jeryl L. Hilleman, Chief Financial Officer at Intersect ENT, Inc. (XENT), sold 72,400 shares at $32.07 ($2.3M) on 2019-04-01, disclosed to the SEC on 2019-04-03.
Open-market sale of $2.3M XENT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.07 | 30,000 | $962K | 41.2% |
| 2 | $32.34 | 4,709 | $152K | 6.5% |
| 3 | $32.34 | 16,491 | $533K | 22.9% |
| 4 | $32.34 | 4,709 | $152K | 6.5% |
| 5 | $32.34 | 16,491 | $533K | 22.9% |
| Total | $32.23 avg | 72,400 |
| $2.3M |
| 100% |
| Filing → |
| SIBN | SELL | 2023-06-20 | $178K | — | Filing → |
| NVCR | SELL | 2022-06-16 | $28K | — | Filing → |
| SIBN | SELL | 2022-06-14 | $27K | — | Filing → |